[Invasive mucormycosis in patients with hemoblastosis in St.-Petersburg].
Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infection. The risk factors, etiology, basic clinical signs and strategy in the treatment of mucormycosis were analyzed.
S N
SN
Khostelidi
A G
AG
Volkova
M O
MO
Popova
T S
TS
Bogomolova
A S
AS
Kolbin
É G
ÉG
Boĭchenko
É I
ÉI
Podol'tseva
A V
AV
Klimovich
M B
MB
Belogurova
N V
NV
Medvedeva
I S
IS
Ziuzgin
L S
LS
Zubarovskaia
N V
NV
Vasil'eva
N N
NN
Klimko
D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality; D011446:Prospective Studies; D012233:Rhizopus / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification; D012307:Risk Factors; D012426:Russia; D016019:Survival Analysis
D000935:Antifungal Agents